Open AccessAdverse Events of Tyrosine Kinase Inhibitors in Patients with Advanced Thyroid Cancer
Author(s) -
Min Joo Kim,
Young Joo Park
Publication year - 2018
Publication title -
international journal of thyroidology
Language(s) - English
Resource type - Journals
eISSN - 2466-1899
pISSN - 2384-3799
DOI - 10.11106/ijt.2018.11.2.61
Subject(s) - lenvatinib , medicine , adverse effect , vandetanib , sorafenib , thyroid cancer , oncology , randomized controlled trial , asymptomatic , cancer , clinical trial , refractory (planetary science) , intensive care medicine , pharmacology , physics , astrobiology , hepatocellular carcinoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom